S. Gok Et Al. , "The safety profile of favipiravir in COVID-19 patients with severe renal impairment," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12, 2021
Gok, S. Et Al. 2021. The safety profile of favipiravir in COVID-19 patients with severe renal impairment. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12 .
Gok, S., Bahcecioglu, O. F., DURMUŞ, M., GÜN, Z. Ü., ERSOY, Y., AYTEMUR, Z. A., ... ULUTAŞ, Ö.(2021). The safety profile of favipiravir in COVID-19 patients with severe renal impairment. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12.
Gok, Selim Et Al. "The safety profile of favipiravir in COVID-19 patients with severe renal impairment," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12, 2021
Gok, Selim Et Al. "The safety profile of favipiravir in COVID-19 patients with severe renal impairment." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12, 2021
Gok, S. Et Al. (2021) . "The safety profile of favipiravir in COVID-19 patients with severe renal impairment." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12.
@article{article, author={Selim Gok Et Al. }, title={The safety profile of favipiravir in COVID-19 patients with severe renal impairment}, journal={INTERNATIONAL JOURNAL OF CLINICAL PRACTICE}, year=2021}